AlphaFold predicted structure
PPP1CB · P62140

Mean pLDDT
91.6/ 100
Very high
327 residues
Confidence breakdown
- Very high(≥ 90)87%
- Confident(70–90)3%
- Low(50–70)1%
- Very low(< 50)9%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
protein phosphatase 1 catalytic subunit beta
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
DDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownMonogenic short stature
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownPaediatric or syndromic cardiomyopathy
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownPigmentary skin disorders
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownPrimary lymphoedema
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownRASopathies
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown+3 more panels — install the extension to see the full list inline on any page.
Noonan syndrome-like disorder with loose anagen hair 2
Noonan syndrome-like disorder with loose anagen hair
Noonan syndrome
neurodegenerative disease
RASopathy
Abnormality of the cardiovascular system
autoimmune disorder of central nervous system
Abnormality of the skeletal system
hereditary disease
carcinoma of esophagus
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Serine/threonine-protein phosphatase PP1-beta catalytic subunit
Protein phosphatase that associates with over 200 regulatory proteins to form highly specific holoenzymes which dephosphorylate hundreds of biological targets. Protein phosphatase (PP1) is essential for cell division, it participates in the regulation of glycogen metabolism, muscle contractility and protein synthesis. Involved in regulation of ionic conductances and long-term synaptic plasticity. Component of the PTW/PP1 phosphatase complex, which plays a role in the control of chromatin structure and cell cycle progression during the transition from mitosis into interphase. In balance with CSNK1D and CSNK1E, determines the circadian period length, through the regulation of the speed and rhythmicity of PER1 and PER2 phosphorylation. May dephosphorylate CSNK1D and CSNK1E. Dephosphorylates the 'Ser-418' residue of FOXP3 in regulatory T-cells (Treg) from patients with rheumatoid arthritis, thereby inactivating FOXP3 and rendering Treg cells functionally defective (PubMed:23396208). Core component of the SHOC2-MRAS-PP1c (SMP) holophosphatase complex that regulates the MAPK pathway activation (PubMed:35768504, PubMed:35831509, PubMed:36175670). The SMP complex specifically dephosphorylates the inhibitory phosphorylation at 'Ser-259' of RAF1 kinase, 'Ser-365' of BRAF kinase and 'Ser-214' of ARAF kinase, stimulating their kinase activities (PubMed:35768504, PubMed:35831509, PubMed:36175670). The SMP complex enhances the dephosphorylation activity and substrate specificity of PP1c (PubMed:35768504, PubMed:36175670)
Curated MONDO disease pages that list PPP1CB among their top associated genes.
PPP1CB · P62140

Mean pLDDT
91.6/ 100
Very high
327 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0